Lot Eye Drop contains Loteprednol etabonate 5 mg, a corticosteroid used primarily for its potent anti-inflammatory and immunosuppressive properties in ophthalmic conditions. It is indicated for the treatment of inflammatory disorders of the eye, including allergic conjunctivitis, postoperative inflammation following ocular surgery, and anterior uveitis. Loteprednol etabonate acts by inhibiting multiple inflammatory cytokines, thereby reducing edema, fibrin deposition, capillary dilation, and migration of inflammatory cells. The formulation is designed for topical ocular administration, ensuring targeted delivery with minimal systemic absorption. Patients should use Lot Eye Drop as prescribed, typically instilling one or two drops into the affected eye(s) two to four times daily, with dosage adjustments based on clinical response. Caution is advised in patients with ocular infections, glaucoma, or a history of corticosteroid-induced intraocular pressure elevation. Prolonged use may increase the risk of cataract formation and secondary ocular infections; therefore, regular ophthalmic monitoring is recommended. Lot Eye Drop is contraindicated in viral, fungal, or mycobacterial eye infections. Adverse effects may include transient burning or stinging upon instillation, increased intraocular pressure, and blurred vision. This medication should be used under strict medical supervision to ensure safety and efficacy in managing ocular inflammation.